ApprovalTrail

Approval · Notice of Compliance 10099 · 2009

ZILMAX: Notice of Compliance 10099

Issued March 18, 2009

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
10099
Date
March 18, 2009
Company
Intervet Canada CorpKirkland, Quebec, Canada
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Beta-adrenergic agonist

Products in this notice

BrandDINStatus today
ZILMAX02324121Dormant

Medicinal ingredients